Restylane Defyne
Sponsors
Galderma R&D, John C Meyer, MD, Erevna Innovations Inc.
Conditions
Chin AugmentationChin RetrusionDry EyeJawline Contour DeficitLower Face Folds and LinesMild to Moderate Dry Eye DiseaseNasolabial Folds in Chinese PopulationVolume Deficiency of the Midface
Unknown Phase
Restylane Defyne Compared to Restylane for Correction of Moderate to Severe Nasolabial Folds
CompletedNCT03003130
Start: 2017-01-16End: 2018-09-14Updated: 2023-11-03
Restylane Defyne for Correction of Chin Retrusion
CompletedNCT03597256
Start: 2018-10-08End: 2020-09-09Updated: 2024-06-12
A Study to Evaluate the Safety and Efficacy of Restylane Defyne for Chin Augmentation and Correction of Chin Retrusion
CompletedNCT03624816
Start: 2018-08-21End: 2020-02-20Updated: 2022-10-06
A Study to Evaluate the Safety and Effectiveness of Restylane-Defyne for Punctual Occlusion
CompletedNCT03709641
Start: 2018-10-17End: 2018-11-28Updated: 2018-12-10
A Study to Evaluate Effectiveness and Safety of Hyaluronic Acid (HA) Fillers
CompletedNCT03869450
Start: 2018-11-09End: 2019-08-30Updated: 2022-08-26
A Study to Evaluate the Safety and Effectiveness Assessments of Restylane-Defyne for Punctual Occlusion
CompletedNCT04022382
Start: 2019-07-18End: 2019-08-26Updated: 2019-09-06
Restylane Defyne in a Stepwise Treatment Approach
CompletedNCT04520997
Start: 2020-12-07End: 2021-09-15Updated: 2023-04-14
Safety and Efficacy of Fillers for Contouring the Jawline
CompletedNCT06336759
Start: 2021-11-11End: 2023-11-10Updated: 2024-05-23
A Restylane Treatment Algorithm Approach for Participants With Appearance of Insufficient Bone Structure in the Lower Face Alone or in Combination With Facial Soft Tissue Deficiencies
CompletedNCT06428214
Start: 2024-05-13End: 2024-09-24Updated: 2025-01-31